The state of New Hampshire currently has 1 active clinical trials seeking participants for Crohn's Disease research studies. These trials are conducted in various cities, including Lebanon, Manchester, Nashua and Concord.
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
2 years and above
Trial Updated:
Locations: Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
Conditions: Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis